Novabay Pharmaceuticals IncのSMA 50
Novabay Pharmaceuticals IncのSMA 50は何ですか。
Novabay Pharmaceuticals IncのSMA 50は$1 -68.74%です。
SMA 50の定義は何ですか。
SMA 50は、過去50日間の終値の非加重平均として計算された過去50日間の平均株価である。
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NYSEMKTのセクタHealth CareにおけるSMA 50の企業と比べるNovabay Pharmaceuticals Inc
Novabay Pharmaceuticals Incは何をしますか。
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Novabay Pharmaceuticals Incと類似のsma 50
- Teuton ResourcesのSMA 50は$1 +18.84%です。
- Spark PowerのSMA 50はCAD$1 +1.88%です。
- AirNet TechnologyのSMA 50は$1 -136.76%です。
- Arts Optical InternationalのSMA 50は$1 -0.94%です。
- Future EnterprisesのSMA 50は₨1 +13.10%です。
- Solitario Resources CorpのSMA 50は$1 -13.64%です。
- Novabay Pharmaceuticals IncのSMA 50は$1 -68.74%です。
- ImmunoPrecise AntibodiesのSMA 50は$1 -27.46%です。
- EVRAZ PlcのSMA 50はGBX1 +99.00%です。
- Galeo Concept SAのSMA 50は€1 +53.71%です。
- ESG Capital 1のSMA 50はCAD$1 -35.00%です。
- Acorn Capital Investment FundのSMA 50はAUD$1 -0.76%です。
- China Molybdenum CoのSMA 50は$1 -17.57%です。